Dow Up 0.17% Nasdaq Down 0.38%

Durata Therapeutics, Inc. (DRTX)

-NasdaqGM
13.90 Down 0.26(1.84%) 1:39PM EDT - Nasdaq Real Time Price
Prev Close:14.16
Open:14.25
Bid:13.90 x 100
Ask:13.95 x 300
1y Target Est:21.75
Beta:3.54
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:13.82 - 14.37
52wk Range:8.30 - 18.17
Volume:107,297
Avg Vol (3m):320,167
Market Cap:372.20M
P/E (ttm):N/A
EPS (ttm):-2.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for DRTX

Comparison

Symbol% ChgMkt Cap
DRTXDown 1.84%372.20M
CBSTDown 0.76%5.04B
PFEDown 0.50%192.93B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.88
Quarterly EPS Est (Sep-14) :-0.84
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-0.19

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Durata Therapeutics, Inc., a pharmaceutical company, focuses on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback